This clinical-stage biotech advances oncology therapies with a pipeline of novel small molecule inhibitors for hard-to-treat ...

Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9, Nuvation Bio Inc. (NYSE:NUVB) ...

Shares of Nuvation Bio (NYSE: NUVB) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday. The big jump came after two positive developments for the cancer-focused drugmaker. Which news ...

Nuvation Bio upgraded to Hold as IBTROZI adoption improves, but competition and pipeline risks loom. Click here to read my latest analysis of NUVB stock.

ImmunityBio's stock has roughly quintupled so far in 2026 as the company continues to deliver good news for investors.

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...